CJC-1295 w/o DAC + Ipamorelin 10mg/10mg Peptides
Built for disciplined labs, this dual-peptide vial delivers reliable consistency for controlled, protocol-driven research.
This CJC-1295 w/o DAC + Ipamorelin lyophilized peptide vial is a growth hormone secretagogue pairing prepared for laboratory workflows. Format: peptide lyophilized vial; style: unflavored; active ingredient type: GH secretagogue peptides; total strength: 20mg per vial (10mg/10mg).
- 10mg CJC-1295 w/o DAC – A GHRH analog valued in study designs that examine short-acting, pulse-oriented signaling dynamics and timing characteristics.
- 10mg Ipamorelin – A selective ghrelin receptor agonist often chosen to complement GHRH analogs for exploring coordinated receptor engagement and signal synergy in controlled models.
Prepared as a lyophilized powder to support structural integrity and dependable handling, this vial is suited to qualified laboratory personnel who require predictable performance and clean, repeatable setup conditions. Researchers commonly select this two-peptide format to investigate receptor-specific activity, temporal patterning, and comparative response profiles under tightly managed variables. When properly handled and reconstituted by trained staff following institutional procedures, the material is designed to integrate smoothly into established assay workflows.
Ingredients: CJC-1295 w/o DAC, Ipamorelin.
Peptide Scientific Labs operates with a strict quality-first approach: each lot is tested for identity and purity (HPLC/MS), supported by batch traceability and clear documentation. As a USA-based research supplier, we emphasize careful sourcing, controlled handling, and transparent specifications so investigators can proceed with confidence. Certificates of Analysis are available for review, and every vial is prepared with attention to consistency from receipt to study completion.
Research Use Only: Not for human consumption or injection. Not for diagnostic, therapeutic, or veterinary use. For laboratory research by qualified professionals only. Follow all applicable regulations, institutional guidelines, and safety practices. Store and handle according to standard laboratory procedures; protect from heat and light and maintain appropriate environmental controls to preserve material integrity.
With an exacting focus on purity, consistency, and documentation, this CJC-1295 w/o DAC + Ipamorelin vial provides a dependable foundation for rigorous, methodical research.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.